HYPD Earnings Date & History
Hyperion DeFi Inc (NASDAQ NMS - GLOBAL MARKET) earnings schedule, consensus estimates and reported results for the last eight quarters.
Last updated Aug 19, 2026 at 7:34 PM ET
Hyperion DeFi Inc
Pharmaceuticals
- Next earnings date
- Wednesday, November 11, 2026
- Reporting session
- Time TBD
- EPS estimate
- $-0.04
- Revenue estimate
- $459,000
HYPD earnings history
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Wednesday, August 12, 2026 | Q2 2026 | $0.94 | $0.92 | -2.0% | $360,000 |
| Thursday, May 14, 2026 | Q1 2026 | $0.74 | $0.26 | -65.1% | $244,000 |
| Thursday, March 26, 2026 | Q4 2025 | $-4.71 | $-7.76 | -64.7% | $496,230 |
What the market is watching in HYPD's next report
- The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
- Ticker Read combines trend, relative strength and catalysts in one research view.
- Scanners, Impact Radar and the members-only Weekly Watchlist are included.
Get the week's earnings by email
One free email each week: the reports that matter, when they land, and what the market is watching.
Frequently asked questions
- When is the next HYPD earnings date?
- Hyperion DeFi Inc is scheduled to report on Wednesday, November 11, 2026 (Time TBD). Dates can change until the company confirms them.
- Does HYPD report before or after the market?
- The next report is scheduled time tbd.
- What EPS is expected for HYPD?
- Consensus EPS for the upcoming quarter is $-0.04, on revenue of $459,000.
Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.
HYPD earnings discussion
Anyone can read. Any free Hyper Stocks account can join in.
Create a free account to join the discussion. Reading is open to everyone — commenting is free, no subscription needed.
Loading discussion…
Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.